Australian Medicines Terminology (AMT) v3 model release

The National Clinical Terminology and Information Service (NCTIS) is pleased to announce that the first release of the Australian Medicines Terminology (AMT) in the v3 model format is now available.

The AMT v3 model has been designed to simplify the AMT v2 model to make it easier to understand and implement, and also to align with the IHTSDO SNOMED CT Release Format 2 specifications. A number of the changes made were informed by stakeholder engagement during the Model Review project.

Further feedback gathering on the AMT v3 occurred after release of the AMT v3 Beta, through workshops, online surveys and webinars.

Detailed explanations of the changes made to the AMT model, components and artefacts can be found in the [The National Clinical Terminology and Information Service (NCTIS) is pleased to announce that the first release of the Australian Medicines Terminology (AMT) in the v3 model format is now available.

The AMT v3 model has been designed to simplify the AMT v2 model to make it easier to understand and implement, and also to align with the IHTSDO SNOMED CT Release Format 2 specifications. A number of the changes made were informed by stakeholder engagement during the Model Review project.

Further feedback gathering on the AMT v3 occurred after release of the AMT v3 Beta, through workshops, online surveys and webinars.

Detailed explanations of the changes made to the AMT model, components and artefacts can be found in the]1 and the AMT v3 Beta Feedback Summary Results found on the NEHTA website.

AMT is updated, verified and validated, and released monthly to incorporate new content, enhance existing content, and make more effective use of the terminology.

Further implementation collateral can be found here as follows:

Australian Medicines Terminology v2 to v3 Migration Guide and the AMT v3 Beta Feedback Summary Results found on the NEHTA website.